AF
EIGR

Amalgamated Financial’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Amalgamated Financial’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$32K Buy
+129
New +$20.4K ﹤0.01% 2604

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's EIGR Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2022: 129 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #2604 among its holdings.

94 funds tracked by Wall St. Rank hold EIGR as of Q1 2022.

  • Amalgamated Financial held 129 shares of Eiger BioPharmaceuticals, Inc. worth $32K as of Q1 2022.
  • Eiger BioPharmaceuticals, Inc. was a new Amalgamated Financial position in Q1 2022.
  • Eiger BioPharmaceuticals, Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2604 holding.
  • 94 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.